Compare
Lilly (Eli) vs Phibro Animal Health (LLY vs PAHC)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Lilly (Eli) (LLY) returned +46.2% and Phibro Animal Health (PAHC) -19.9%; so far this year the figures are +26.0% and -11.8%.
Lilly (Eli) is the larger company by market value, about 943.5 times the size of Phibro Animal Health.
On trailing earnings, LLY trades at 43.9 times and PAHC at 13.1 times.
Revenue grew +45.5% at LLY and +10.1% at PAHC over the last year.
LLY yields 0.49%. PAHC yields 1.46%.
Data as of the latest close. Not investment advice.
Relative performance
| LLY | PAHC | |
|---|---|---|
| Price | $1,354.00 | $32.96 |
| 1-day | -0.79% | -6.89% |
| YTD | +25.99% | -11.78% |
| 1 year | +46.25% | -19.90% |
| 3 years | +144.20% | +194.55% |
| Market cap | $1.27T | $1.4B |
| P/E | 43.9 | 13.1 |
| P/S | 14.73 | 0.88 |
| P/B | 31.63 | 3.23 |
| Revenue growth | +45.50% | +10.10% |
| EPS growth | +50.70% | +50.30% |
| Gross margin % | 83.6 | 33.8 |
| Net margin % | 31.9 | 6.7 |
| ROE % | 68.5 | 24.6 |
| Debt / equity | 1.23 | 1.46 |
| FCF yield % | 2.4 | 1.6 |
| Dividend yield % | 0.49 | 1.46 |
| Beta | 0.29 | 0.92 |
| RSI (14) | 61.1 | 33.0 |
| Technical rating |